Labetuzumab Govitecan Biosimilar - Research Grade

Human

CEACAM5 / CEA / CD66e

1mg/ml

IgG1

CHO Cells

P06731

Room Temp

Carcinoembryonic antigen (CEACAM5, CEA, CD66e) is overexpressed across many epithelial tumors and serves as a well-validated oncology target. This human IgG1 reagent is an unconjugated, non-therapeutic analog of labetuzumab govitecan and may support antibody-drug-conjugate (ADC) research, though it is supplied without payload or linker. It is intended for research use only (RUO), formulated with low endotoxin for in vivo studies, and manufactured in milligram to gram quantities to serve bulk and high-throughput users. Applications encompass target-binding and internalization assays, in vitro screening, and preclinical tumor models, where it functions as a consistent reference reagent during functional and antibody-development research.

SN38

25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

Reconstitute with sterile, distilled water to a final concentration of 1 mg/ml. Gently shake to solubilize completely. Do not vortex.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

1 week